ArticleTherapeutic innovation & regulatory science2026
Research on the Quality Evaluation Indicators of Real-World Data in the Review of Anti-Tumor Drugs for Chinese Regulatory Frameworks.
Jie-Ying Zhang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.